Is MGTX or VOR more profitable?

MGTX runs the higher net margin — MGTX at 19.87% versus VOR at 0.00%.

How have MGTX and VOR total returns compared?

Over the past 5 years, MGTX delivered -3.10% and VOR delivered -42.54% annualized total return. Past performance doesn't predict future results.

MeiraGTx Holdings plc (MGTX) vs Vor Biopharma Inc. (VOR)

A side-by-side comparison of MeiraGTx Holdings plc and Vor Biopharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

MGTX

MeiraGTx Holdings plc

$982M

$10.60HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

VOR

Vor Biopharma Inc.

$992M

$18.31HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — MGTX vs VOR

growth of $100 · dividends reinvested · last 6y

MGTX -31.1% (-6.0%/yr)VOR -97.5% (-46.0%/yr)MGTX compounded faster over this window

Log scale — wide-divergence pair

MGTX VOR

MGTX vs VOR: by the numbers

•VOR is the larger company ($992M vs $982M market cap).
•MGTX is profitable (19.87% net margin) while VOR runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	MGTX	VOR
P/E ratio	14.93	N/A
Forward P/E	35.33	N/A
P/S ratio	2.47	N/A
P/B ratio	4.55	N/A
EV / EBITDA	4.84	N/A

Profitability

Metric	MGTX	VOR
Gross margin	97.19%	0.00%
Operating margin	-130.20%	0.00%
Net margin	19.87%	0.00%
ROE	36.64%	N/A
ROIC	52.81%	-32.24%

Growth (annualized)

Metric	MGTX	VOR
Revenue CAGR (5Y)	84.52%	N/A
Total return CAGR (5Y)	-3.10%	-42.54%

Some values include inputs from SEC filing.

Frequently asked

Is MGTX or VOR more profitable?: MGTX runs the higher net margin — MGTX at 19.87% versus VOR at 0.00%.
How have MGTX and VOR total returns compared?: Over the past 5 years, MGTX delivered -3.10% and VOR delivered -42.54% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MGTX analysis Full VOR analysis Interactive comparison tool

Dig into the metrics

MeiraGTx P/E ratio MeiraGTx ROE Vor Biopharma ROE MeiraGTx operating margin Vor Biopharma operating margin MeiraGTx revenue growth Vor Biopharma revenue growth MeiraGTx free cash flow Vor Biopharma free cash flow

MeiraGTx & Vor Biopharma appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.